HDAC9 and breast carcinoma: In the pathological process of cancer, HDAC9, as an oncogene, confers migratory, invasive, and angiogenic potential in various malignancies, including breast cancer, oral squamous cell carcinoma (OSCC), lymphoma, and medulloblastoma (12–15).